Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis

Código QR

Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis

Jacob E Michalski, David A Schwartz Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USACorrespondence: David A SchwartzUniversity of Colorado School of Medicine, 12631 East 17th Avenue, B178, Aurora, CO 80045, USATel +1 303-724-1783Fax +1 303-724-1799Email david.schwar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Michalski JE, Schwartz DA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	pulmonary fibrosis interstitial lung disease genetics muc5b host defense innate immunity Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/a2552b8d6e354ff699a30fdd71c59798
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
por: Manolescu D, et al.
Publicado: (2018)

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
por: Cao X, et al.
Publicado: (2021)

MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice
por: Pan J, et al.
Publicado: (2021)

Diagnosis of Idiopathic Pulmonary Fibrosis in a Possible Usual Interstitial Pneumonia Pattern: a meta-analysis
por: Heekyung Kim, et al.
Publicado: (2018)

Editorial: From Development to Senescence, Bridging the Gap in Lung Fibrosis
por: Jason J. Gokey
Publicado: (2021)

Enfermedades pulmonares intersticiales. Una perspectiva actual
por: SALINAS,MAURICIO, et al.
Publicado: (2019)

Interstitial lung abnormalities – current knowledge and future directions
por: Gisli Thor Axelsson, et al.
Publicado: (2021)

The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
por: Coline H. M. van Moorsel, et al.
Publicado: (2021)

Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis
por: Todd NW, et al.
Publicado: (2013)

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese
por: Köster LS, et al.
Publicado: (2016)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
por: Zhang Y, et al.
Publicado: (2021)

Neumonía intersticial inducida por bloqueo androgénico máximo como tratamiento de cáncer de próstata avanzado: Report of one case
por: Molina Mancero,Guillermo, et al.
Publicado: (2016)

Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
por: Xue L, et al.
Publicado: (2021)

Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation
por: Persson HL, et al.
Publicado: (2020)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
por: Katarzyna Walicka-Serzysko, et al.
Publicado: (2021)

Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Amigues I, et al.
Publicado: (2019)

High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
por: Leona M. Dowman, et al.
Publicado: (2021)

Quantification of Cancer-Developing Idiopathic Pulmonary Fibrosis Using Whole-Lung Texture Analysis of HRCT Images
por: Chia-Hao Liang, et al.
Publicado: (2021)

Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
por: Gian Marco Manzetti, et al.
Publicado: (2021)

The Link between Circadian Clock Genes and Autophagy in Chronic Obstructive Pulmonary Disease
por: Yuedi Hu, et al.
Publicado: (2021)

Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis
por: Read SA, et al.
Publicado: (2021)

NOD1/2 and the C-Type Lectin Receptors Dectin-1 and Mincle Synergistically Enhance Proinflammatory Reactions Both In Vitro and In Vivo
por: Tukhvatulin AI, et al.
Publicado: (2020)

NOD2 and inflammation: current insights
por: Negroni A, et al.
Publicado: (2018)

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
por: Kexiong Zhang, et al.
Publicado: (2021)

CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
por: Yupeng Li, et al.
Publicado: (2021)

Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases
por: Wang W, et al.
Publicado: (2021)

Variability in Global Prevalence of Interstitial Lung Disease
por: Bhavika Kaul, et al.
Publicado: (2021)

CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
por: Aya Fukuizumi, MD, et al.
Publicado: (2021)

New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021)

Oxidant-induced autophagy and ferritin degradation contribute to epithelial–mesenchymal transition through lysosomal iron
por: Sioutas A, et al.
Publicado: (2017)

Case Report: Delayed Lung Transplantation With Intraoperative ECMO Support for Herbicide Intoxication-Related Irreversible Pulmonary Fibrosis: Strategy and Outcome
por: Guohui Jiao, et al.
Publicado: (2021)

Volumetric Imaging of Lung Tissue at Micrometer Resolution: Clinical Applications of Micro-CT for the Diagnosis of Pulmonary Diseases
por: Andreana Bompoti, et al.
Publicado: (2021)

Effect of home-based pulmonary rehabilitation on functional capacity in people with idiopathic pulmonary fibrosis—a systematic review protocol
por: Revati Amin, et al.
Publicado: (2021)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar S, et al.
Publicado: (2020)

Role of IFN and Complements System: Innate Immunity in SARS-CoV-2
por: Shibabaw T, et al.
Publicado: (2020)

Epigallocatechin-3-gallate suppresses neutrophil migration speed in a transgenic zebrafish model accompanied by reduced inflammatory mediators
por: Nguyen T, et al.
Publicado: (2019)

Murine models for studying immunopathogenesis in gastrointestinal lesions: How to go about it
por: Neharika Jain, et al.
Publicado: (2021)

Inflammasome as an Effective Platform for Fibrosis Therapy
por: Chen TT, et al.
Publicado: (2021)

Di-Tyrosine Crosslinking and <i>NOX4</i> Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis
por: Sanja Blaskovic, et al.
Publicado: (2021)

Identification of Key Genes Associated with Changes in the Host Response to Severe Burn Shock: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database
por: Fang X, et al.
Publicado: (2020)